Tiny study to watch MUSE stem cells in brain injury patients seeking treatment abroad

NCT ID NCT07326059

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will follow 10 people aged 6 to 75 with chronic traumatic brain injury who choose to get MUSE stem cell therapy outside the U.S. Researchers will not give any treatment but will track safety, brain function, and quality of life for 12 months. The goal is to gather real-world information that could guide future research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MUSE stem cells
What this could lead to
If results are promising, this could point toward a larger trial to test whether MUSE stem cells help repair brain damage from TBI.
What could go wrong
This is a very small observational study (10 people) with no control group, so it cannot prove the therapy works. Participants seek treatment abroad, which may have variable quality and safety standards.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRAUMATIC BRAIN INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Brain Concussion Brain Injuries, Traumatic brain injury dementia pugilistica traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Healing Hope International

    Houston, Texas, 77386, United States

  • Stem Solutions

    Monterrey, Nuevo León, 66278, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.